Immune haemolytic anaemia induced by glibenclamide in selective IgA deficiency.
D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D004406:Dysgammaglobulinemia / Q000188:drug therapy*; D005905:Glyburide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D017098:IgA Deficiency; D008297:Male; D008875:Middle Aged
D005905:Glyburide